Serum Galectin-3 Correlates with Frailty Risk
In this study, we aimed to address the change of Gal-3 levels in human whole blood with frailty. We performed serum biochemical and peripheral blood mononuclear cells (PBMC) microarray analyses in humans to determine the secretory phenotype characteristics of frailty. Furthermore, we used the frail mouse model to study the significantly altered behavioral phenotype and associated secreted Gal-3 levels in blood samples to reveal the Gal-3-dependent inflammatory dysregulation of frailty.
Source: Fight Aging! - Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
More News: Biotechnology | Brain | Cancer & Oncology | Cardiology | Cardiovascular | Eating Disorders & Weight Management | Environmental Health | Heart | Liver | Neurology | Obesity | Research | Stem Cell Therapy | Stem Cells | Study | Urology & Nephrology